0001209191-21-070249.txt : 20211217 0001209191-21-070249.hdr.sgml : 20211217 20211217161037 ACCESSION NUMBER: 0001209191-21-070249 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211215 FILED AS OF DATE: 20211217 DATE AS OF CHANGE: 20211217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pitman Jama CENTRAL INDEX KEY: 0001852595 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38219 FILM NUMBER: 211501636 MAIL ADDRESS: STREET 1: C/O DECIPHERA PHARMACEUTICALS, INC. STREET 2: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200299725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-209-6400 MAIL ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC DATE OF NAME CHANGE: 20150928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-15 0 0001654151 Deciphera Pharmaceuticals, Inc. DCPH 0001852595 Pitman Jama C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451 0 1 0 0 See Remarks Common Stock 2021-12-15 4 A 0 8300 0.00 A 25438 D Stock Option (Right to Buy) 9.23 2021-12-15 4 A 0 62971 0.00 A 2031-12-14 Common Stock 62971 62971 D The reporting person was awarded 8,300 Restricted Stock Units ("RSUs") under the Issuer's 2017 Stock Option and Incentive Plan (the "2017 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in two equal installments on June 15, 2022 and June 15, 2023, subject to continued service with the Issuer or a Subsidiary (as defined in the 2017 Plan) through such dates. The RSUs may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. This number includes (i) 5,280 RSUs issued pursuant to the 2017 Plan which vest in three (3) equal annual installments on each of February 15, 2022, 2023 and 2024; and (ii) 8,300 RSUs issued pursuant to the 2017 Plan which vest in equal annual installments over four (4) years beginning on February 15, 2022. Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Includes 145 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on November 12, 2021. This stock option was issued pursuant to the 2017 Plan. The option shall vest in two equal installments on June 15, 2022 and June 15, 2023, subject to continuous service with the Issuer or a Subsidiary (as defined in the 2017 Plan) through each vesting date. Title: SVP, Regulatory, Quality, & Portfolio Management /s/ Jeffrey Held, Attorney-in-Fact 2021-12-17